Early cellular and molecular changes induced by diabetes in the retina

Diabetologia

Volumn 44, Issue 7, 2001, Pages 791-804

  Lorenzi, M ^a   Gerhardinger, C ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Diabetic retinopathy; Endothelial cells; Glia; Human diabetes; Inflammation; Neural retina; Pericytes; Streptozotocin diabetic rat; Thrombosis

Indexed keywords

APOPTOSIS; CELL TYPE; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; GLIA; HISTOPATHOLOGY; HUMAN; MICROANGIOPATHY; MICROTHROMBUS; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA NEUROEPITHELIAL LAYER; REVIEW;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; HUMANS; RETINA;

EID: 0034933340     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100544     Document Type: Review

References (109)

1. Diabetes mellitis and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973
2. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
4. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
5. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
6. ERG in diabetics
7. From functional to microvascular abnormalities in early diabetic retinopathy
8. Neural conduction in visual pathways in newly-diagnosed IDDM patients
9. Extreme diversity among amacrine cells: Implications for function
10. Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa
11. Localization of NADPH-diaphorase/nitric oxide synthase in the rat retina: An electron microscopic study
12. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: Reversal by aminoguanidine
13. Diabetes-induced vascular dysfunction in the retina: Role of endothelins
14. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment
15. B gene expression in chronic diabetes
16. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1
17. Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes
18. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats
19. Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor
20. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels
21. Glucose transport in brain and retina: Implications in the management and complications of diabetes
22. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-α, but not by insulin
23. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas
24. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
25. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor
26. The biology of vascular endothelial growth factor
27. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
28. Glial reactivity, an early feature of diabetic retinopathy
29. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells
30. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin
31. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy
32. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas
33. IGF-I mRNA and signaling in the diabetic retina
34. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis
35. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta
36. Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye
37. Insulin-like growth factors and diabetes
38. Coordinate decrease of tissue insulin-like growth factor I post-transcriptional alternative mRNA transcripts in diabetes mellitus
39. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye
40. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy
41. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
42. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy
43. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
44. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
45. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes
46. Structure of the macroglia of the retina: Sharing and division of labour between astrocytes and Müller cells
47. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro
48. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina
49. Immunohistochemical localization of aldose reductase. II. Rat eye and kidney
50. Localization of aldose reductase in the human eye
51. The Müller cell: A functional element of the retina
52. Induction of blood-brain barrier endothelial cell differentiation
53. The role of Müller cells in the formation of the blood-retinal barrier
54. Glial cell involvement in vascular occlusion of diabetic retinopathy
55. Müller cell changes in human diabetic retinopathy
56. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy
57. Altered expression of retinal occludin and glial fibrillar acidic protein in experimental diabetes
58. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
59. Molecular profile of reactive astrocytes-implications for their role in neurologic disease
60. In situ kinetics of glucose transport across the blood-retinal barrier in normal rats and rats with streptozocin-induced diabetes
61. Down-regulation of glucose transport by elevated extracellular glucose concentrations in cultured rat aortic smooth muscle cells does not normalize intracellular glucose concentrations
62. Pathological upregulation of inner blood-retinal barrier Glut 1 glucose transporter expression in diabetes mellitus
63. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats
64. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
65. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine
66. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants
67. Pathophysiology of diabetic retinopathy
68. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessels abnormalities in diabetic rats
69. Prevention of pericyte loss by trolox in diabetic rat retina
70. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm
71. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
72. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia
73. Retinal vascular endothelial cell endocytosis increases in early diabetes
74. Permeability and patency of retinal blood vessels in experimental diabetes
75. Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage
76. Transmembrane proteins in the tight junction barrier
77. Mechanisms of occludin overexpression in human diabetic retinopathy
78. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
79. Increased expression of basement membrane collagen in human diabetic retinopathy
80. Fibronectin overexpression in retinal microvessels of patients with diabetes
81. Fibronectin in the microvasculature: Localization in the pericyte-endothelial interstitium
82. Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy
83. Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication
84. Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid
85. Measurement of gene expression in human retinal microvessels by solution hybridization
86. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid
87. Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature
88. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
89. A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats
90. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy
91. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes
92. Reperfusion of occluded capillary beds in diabetic retinopathy
93. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats
94. The BB-rat - An authentic model of human diabetic retinopathy
95. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals
96. Apoptotic vascular endothelial cells become procoagulant
97. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules. Evidence for an interleukin-1β-dependent paracrine loop
98. Cell turnover of capillaries
99. Progression of incipient diabetic retinopathy during good glycemic control
100. Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats
101. Pharmacologic inhibition of diabetic retinopathy: Comparison of aminoguanidine and aspirin
102. Retinal blood flow increases following short-term aspirin usage in type 1 diabetics with no or minimal retinopathy
103. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial
104. Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy
105. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data
106. Genes expressed in human tumor endothelium
107. Functional and morphological aspects of impaired TRH release by mediobasal hypothalamus of STZ-induced diabetic rats
108. A mouse model of diabetic retinopathy
109. Multiple genetic loci modify risk for retinoblastoma in transgenic mice